Motus GI (NASDAQ:MOTS) Stock Price Up 16%

Shares of Motus GI Holdings, Inc. (NASDAQ:MOTS) rose 16% on Monday . The stock traded as high as $4.30 and last traded at $4.27. Approximately 80,263 shares traded hands during mid-day trading, an increase of 104% from the average daily volume of 39,368 shares. The stock had previously closed at $3.68.

Analysts Set New Price Targets

MOTS has been the topic of several analyst reports. Alliance Global Partners lowered their target price on Motus GI from $24.75 to $20.25 in a research note on Thursday, August 17th. HC Wainwright reiterated a “buy” rating and issued a $37.50 target price on shares of Motus GI in a research note on Wednesday, September 27th.

Motus GI Stock Performance

The firm has a fifty day moving average price of $6.55 and a 200 day moving average price of $8.57. The firm has a market capitalization of $2.47 million, a price-to-earnings ratio of -0.12 and a beta of 1.79.

Institutional Trading of Motus GI

Hedge funds have recently modified their holdings of the business. Renaissance Technologies LLC acquired a new position in Motus GI during the first quarter worth $26,000. Millennium Management LLC acquired a new position in Motus GI during the fourth quarter worth $31,000. Virtu Financial LLC raised its holdings in Motus GI by 245.3% during the fourth quarter. Virtu Financial LLC now owns 46,810 shares of the company’s stock worth $39,000 after purchasing an additional 33,254 shares during the last quarter. Finally, Armistice Capital LLC raised its holdings in Motus GI by 107.7% during the third quarter. Armistice Capital LLC now owns 567,000 shares of the company’s stock worth $255,000 after purchasing an additional 294,012 shares during the last quarter. 8.61% of the stock is owned by institutional investors and hedge funds.

Motus GI Company Profile

Motus GI Holdings, Inc operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp.